CSIMarket
 


Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 

Atara Biotherapeutics Inc 's Leverage Ratio

ATRA's quarterly Leverage Ratio and Total Liabilities, Equity growth


In III Quarter 2023 Atara Biotherapeutics Inc had stockholder deficit.

Within Biotechnology & Pharmaceuticals industry Atara Biotherapeutics Inc achieved the lowest Leverage Ratio in the third quarter 2023. While total ranking remained the same in the third quarter 2023 compared to the previous quarter at no. .

Explain Leverage Ratio?
Who are ATRA Customers?
What are ATRA´s Total Liabilities?


ATRA Leverage Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change - -97.11 % -71.04 % -54.71 % -39.67 %
Y / Y Total Liabilities Change 32.24 % 33.78 % 37.09 % 32.5 % 29.63 %
Leverage Ratio MRQ - 32.06 3.65 1.97 0.97
ATRA's Total Ranking # # # # #
Seq. Equity Change - -88.53 % -48.7 % -32.32 % -27.33 %
Seq. Total Liabilities Change 0.27 % 0.79 % -5.07 % 37.85 % 1.43 %



Leverage Ratio third quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Atara Biotherapeutics Inc 's Equity $ -51 Millions Visit ATRA's Balance sheet
Atara Biotherapeutics Inc 's Total Liabilities $ 240 Millions Visit ATRA's Balance sheet
Source of ATRA's Sales Visit ATRA's Sales by Geography


Cumulative Atara Biotherapeutics Inc 's Leverage Ratio

ATRA's Leverage Ratio for the trailling 12 Months

ATRA Leverage Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth - -97.11 % -71.04 % -54.71 % -39.67 %
Y / Y Total Liabilities TTM Growth 32.24 % 33.78 % 37.09 % 32.5 % 29.63 %
Leverage Ratio TTM 6.51 2.35 1.33 0.98 0.76
Total Ranking TTM
Seq. Equity TTM Growth - -88.53 % -48.7 % -32.32 % -27.33 %
Seq. Total Liabilities TTM Growth 0.27 % 0.79 % -5.07 % 37.85 % 1.43 %


On the trailing twelve months basis During the 12 months period ending III Quarter 2023 company had stockholder deficit.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 4, during the past 12 months, other companies have achieved lower Leverage Ratio than Atara Biotherapeutics Inc . While total ranking remained unchanged compared to previous 12 month period at no. 88.

Explain Leverage Ratio?
Who are ATRA Customers?
What are ATRA´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 5
Healthcare Sector # 44
Within the Market #


trailing twelve months Leverage Ratio Statistics
High Average Low
6.51 0.64 0.06
(Sep 30 2023)   (Jun 30 2017)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Equity

Date modified: 2023-11-01T19:14:13+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com